Tutorials
Merck & Co Inc logo

Merck & Co Inc

$ 87.41 +0.59 (+0.68%) 10:08 PM EST
P/E:
13.39
P/B:
5.41
Market Cap:
$ 221.04B
Enterprise V:
$ 243.91B
Volume:
8.77M
Avg Vol (2M):
10.70M
Also Trade In:
Volume:
8.77M
Market Cap $:
221.04B
PE Ratio:
13.39
Avg Vol (2-Month):
10.70M
Enterprise Value $:
243.91B
PB Ratio:
5.41
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Merck & Co Inc
NAICS : 325412 SIC : 2834
2000 Galloping Hill Road, Kenilworth, NJ, USA, 07033
Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.

Financials (Next Earnings Date:2022-10-27)

MRK's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:MRK

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 57,169
EPS (TTM) ($) 6.53
Beta 0.35
Volatility % 27.92
14-Day RSI 36.6
14-Day ATR ($) 1.801843
20-Day SMA ($) 90.7715
12-1 Month Momentum % 22.56
52-Week Range ($) 70.89 - 95.72
Shares Outstanding (Mil) 2,528.81

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Merck & Co Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More